114 related articles for article (PubMed ID: 20072157)
41. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
Riedel SS; Lu C; Xie HM; Nestler K; Vermunt MW; Lenard A; Bennett L; Speck NA; Hanamura I; Lessard JA; Blobel GA; Garcia BA; Bernt KM
Mol Cell; 2021 Jun; 81(11):2332-2348.e9. PubMed ID: 33974912
[TBL] [Abstract][Full Text] [Related]
42. Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes.
Garcia-Cuellar MP; Büttner C; Bartenhagen C; Dugas M; Slany RK
Cell Rep; 2016 Apr; 15(2):310-22. PubMed ID: 27050521
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.
Gong S; Guo M; Tang G; Yang J; Qiu H
Chemotherapy; 2018; 63(6):308-314. PubMed ID: 30840968
[TBL] [Abstract][Full Text] [Related]
44. Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies.
Pieters T; T'Sas S; Demoen L; Almeida A; Haenebalcke L; Matthijssens F; Lemeire K; D'Hont J; Van Rockeghem F; Hochepied T; Lintermans B; Reunes L; Lammens T; Berx G; Haigh JJ; Goossens S; Van Vlierberghe P
Sci Rep; 2019 Jul; 9(1):10577. PubMed ID: 31332244
[TBL] [Abstract][Full Text] [Related]
45. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.
Sharma A; Yun H; Jyotsana N; Chaturvedi A; Schwarzer A; Yung E; Lai CK; Kuchenbauer F; Argiropoulos B; Görlich K; Ganser A; Humphries RK; Heuser M
Leukemia; 2015 Jan; 29(1):157-68. PubMed ID: 24957708
[TBL] [Abstract][Full Text] [Related]
46. The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients.
Shafik RE; Hassan NM; El Meligui YM; Shafik HE
Asian Pac J Cancer Prev; 2017 Mar; 18(3):609-613. PubMed ID: 28440611
[TBL] [Abstract][Full Text] [Related]
47. MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells.
Wenge DV; Felipe-Fumero E; Angenendt L; Schliemann C; Schmidt E; Schmidt LH; Thiede C; Ehninger G; Berdel WE; Arteaga MF; Mikesch JH
Oncogenesis; 2015 Dec; 4(12):e179. PubMed ID: 26690545
[TBL] [Abstract][Full Text] [Related]
48. MN1, a novel player in human AML.
Grosveld GC
Blood Cells Mol Dis; 2007; 39(3):336-9. PubMed ID: 17698380
[TBL] [Abstract][Full Text] [Related]
49. A novel retrovirus provides the cooperating oncogenic event(s) required to demonstrate the tumor suppressor activity of p15Ink4b in myeloid cells in vivo.
Wolff L; Garin MT; Koller R; Bies J; Tessarollo L; Anver MR; Powell D; Perella C
Blood Cells Mol Dis; 2004; 32(1):226-31. PubMed ID: 14757439
[TBL] [Abstract][Full Text] [Related]
50. Biologic and experimental variation of measured cancer stem cells.
Heuser M; Humphries RK
Cell Cycle; 2010 Mar; 9(5):909-12. PubMed ID: 20348851
[TBL] [Abstract][Full Text] [Related]
51. The BAFfling story of MN1-induced leukemogenesis.
Stonestrom AJ; Levine RL
Mol Cell; 2021 Jun; 81(11):2268-2269. PubMed ID: 34087176
[TBL] [Abstract][Full Text] [Related]
52. Myeloid Progenitor Transformation Assay.
Okuda H; Yokoyama A
Bio Protoc; 2017 Dec; 7(23):e2626. PubMed ID: 34595294
[TBL] [Abstract][Full Text] [Related]
53. Exploitable metabolic dependencies in MLL-ENL-induced leukemia.
Garcia-Cuellar MP; Lawlor J; Böttcher M; Mougiakakos D; Metzler M; Slany RK
Blood Adv; 2020 Aug; 4(15):3626-3638. PubMed ID: 32766858
[TBL] [Abstract][Full Text] [Related]
54. Cell-cycle-specific genes differentially expressed in human leukemias.
Calabretta B; Kaczmarek L; Mars W; Ochoa D; Gibson CW; Hirschhorn RR; Baserga R
Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4463-7. PubMed ID: 3859871
[TBL] [Abstract][Full Text] [Related]
55. A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5.
Griaud F; Pierce A; Gonzalez Sanchez MB; Scott M; Abraham SA; Holyoake TL; Tran DD; Tamura T; Whetton AD
Leukemia; 2013 Apr; 27(4):932-40. PubMed ID: 23032722
[TBL] [Abstract][Full Text] [Related]
56. Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.
Garnar-Wortzel L; Bishop TR; Kitamura S; Milosevich N; Asiaban JN; Zhang X; Zheng Q; Chen E; Ramos AR; Ackerman CJ; Hampton EN; Chatterjee AK; Young TS; Hull MV; Sharpless KB; Cravatt BF; Wolan DW; Erb MA
ACS Cent Sci; 2021 May; 7(5):815-830. PubMed ID: 34079898
[TBL] [Abstract][Full Text] [Related]
57. Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Benbarche S; Lopez CK; Salataj E; Aid Z; Thirant C; Laiguillon MC; Lecourt S; Belloucif Y; Vaganay C; Antonini M; Hu J; da Silva Babinet A; Ndiaye-Lobry D; Pardieu B; Petit A; Puissant A; Chaumeil J; Mercher T; Lobry C
Sci Adv; 2022 Feb; 8(6):eabg9455. PubMed ID: 35138899
[TBL] [Abstract][Full Text] [Related]
58. Oncogenes and acute leukemias.
Goh KO; Qazi R; Owens M; Herrmann M; Bennett JM
Blood; 1984 Jan; 63(1):242. PubMed ID: 6689952
[No Abstract] [Full Text] [Related]
59. [Molecular mechanisms of acute leukemias].
Hirai H
Rinsho Ketsueki; 1997 Mar; 38(3):166-71. PubMed ID: 9095650
[No Abstract] [Full Text] [Related]
60. Corrigendum to "SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia".
Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Zhang J; Li B
Biochem Biophys Res Commun; 2022 Oct; 623():202-204. PubMed ID: 35953314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
